Residual Anti-Xa Activity After Last Treatment Dose of Enoxaparin

Clinical trial NCT03296033 · TERMINATED

Trial details

NCT number: NCT03296033
Sponsor: Wake Forest University Health Sciences
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Anticoagulants and Bleeding Disorders Surgery Regional Anesthesia Morbidity

Start date: 2017-10-24
Primary completion: 2022-01-14
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.